Biology

Scientists create stem cells from rare genetic disorder patient to study disease

How the science connects

Neurodegenerative …Cellular reprogram…Induced pluripoten…

AI Insight

Researchers generated a human induced pluripotent stem cell line from skin fibroblasts of a patient with Skogholt syndrome, a rare inherited neurodegenerative disorder affecting cerebrospinal fluid regulation. The cell line was created using non-integrating reprogramming methods and demonstrated all expected characteristics of pluripotent stem cells, including normal chromosomes, expression of pluripotency markers, ability to differentiate into multiple cell types, and retention of the disease-causing genetic variant. The team also successfully produced choroid plexus-like organoids from these stem cells.


This patient-specific cell line provides a laboratory model to study Skogholt syndrome's underlying mechanisms, particularly how choroid plexus dysfunction leads to impaired cerebrospinal fluid homeostasis. It offers a platform for testing potential treatments for this rare disease and could advance understanding of choroid plexus biology more broadly.


Understand the Science

Neurodegenerative diseases Concept coming soon Cellular reprogramming Concept coming soon Induced pluripotent stem cell Concept coming soon

⚠️ Preprint – Noch nicht peer-reviewed

Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.

We report the generation and characterization of a human induced pluripotent stem cell (iPSC) line derived from dermal fibroblasts of a patient with Skogholt disease, a rare maternally inherited neurodegenerative syndrome associated with choroid plexus dysfunction and impaired cerebrospinal fluid (CSF) homeostasis. Patient fibroblasts were reprogrammed using the non-integrating Repro-OSKGM kit. The resulting iPSC line exhibited typical pluripotent morphology, expressed canonical pluripotency markers, maintained a normal karyotype, retained the disease-associated genetic variant, was mycoplasma-free, and demonstrated trilineage differentiation potential. We also made choroid plexus (ChP) like organoids from the generated iPSCs. This patient-specific iPSC line provides a valuable resource for generating choroid plexus organoids and neurons to investigate disease mechanisms and develop therapeutic strategies.

Source: Generation and characterization of a patient-specific human induced pluripotent stem cell line from a Skogholt syndrome patient (ASCFi003-A)